Akzo Nobel completes OBS sale
"It is with mixed emotions that we say goodbye to these businesses, which have been part of Akzo Nobel for so many years, said CEO Hans Wijers. "I would like to thank all the OBS employees for their contributions. I am convinced that Schering-Plough will prove to be a stimulating new owner, allowing the Pharma activities to flourish and grow. I wish all the people at OBS a successful future."
Schering-Plough's global headquarters will continue to be based in Kenilworth, NJ, in the United States, while Boxmeer in the Netherlands will become the HQ for its worldwide animal health business.
First announced in March, the divestment of Akzo Nobel's pharmaceutical activities means that the company can now concentrate its strategic focus on becoming a world-leading industrial company exclusively dedicated to coatings and specialty chemicals.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.